Dr Wong Mun Yew is the founder & CEO of Asia Genomics. He is also an angel investor, and supports a couple of start-ups in Singapore as advisor and mentor. Mun Yew worked more than 10 years in the investment industry. He was an Asia Business Development Operating Partner at Formation8 Partners 2013-2016, a successful Silicon Valley technology venture capital fund, focusing on Singapore and South East Asia. He began his investment career with Bio*One Capital in 2005, a global healthcare private equity fund, before becoming Senior Vice President at EDB Investments Pte Ltd where he led EDBI’s cleantech investment team. He has served as a director for Codexis Inc. (Nasdaq: CDXS), Amaranth Medical Inc., and was board observer in Fluidigm Corp (Nasdaq: FLDM), Revance Therapeutics (Nasdaq: RVNC) and Innovalight Inc (acquired by DuPont). He also gained experience in business development and operations in healthcare services, and spent time in China as Vice President (International Operations) at Parkway Pantai Limited, a subsidiary of IHH Healthcare Berhad. Prior to investing, Mun Yew practised clinical medicine for 7 years in Singapore. Mun Yew holds a medical degree and Diploma in Dermatology from the National University of Singapore.